LeafNLP Demos
Back to explore

Report #2878867

Received Dec 20, 2025

Reports are unverified and do not show that a vaccine caused an event. Full disclaimer

Overview

Sex
Female
Age
Age unknown
State
PA
Recovered
Unknown
Vaccinated
Sep 9, 2025
Onset
Dec 2, 2025
Days to onset
84
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
HEPHEP B (HEPLISAV-B)DYNAVAX TECHNOLOGIES CORPORATION1945657IM

Symptoms (2)

Incomplete course of vaccinationNo adverse event

Symptom narrative

Received First Dose of HEPLISAV-B In September, Has Not Had The Second Dose; Initial report received on 02-Dec-2025. A pharmacist reported that a 41-year-old female received HEPLISAV-B (hepatitis B vaccine) for hepatitis B immunization on 09-Sep-2025 and has not had the second dose. No medical history or concomitant medications were reported. The patient had no known drug allergy. On 09-Sep-2025, the patient received dose 1 of a hepatitis B vaccine [HEPLISAV-B (lot number 945657; expiration date, NDC number, and site not available)] intramuscularly. As of 02-Dec-2025, 84 days after receiving the first dose of HEPLISAV-B, the patient has not yet received the second dose. No adverse effects were reported. No other information was available. Company Comment: The company assessed the event as non-serious.; Sender's Comments: The company assessed the event as non-serious.